Last updated: August 12, 2025
Introduction
Patent TW200950787, filed in Taiwan, pertains specifically to a pharmaceutical invention with implications for drug formulation, delivery, or manufacturing processes. Precise understanding of its scope, claims, and position within the patent landscape is essential for stakeholders involved in drug development, licensing, or patent infringement assessments. This report offers a comprehensive analysis of the patent's scope, claims, and placement within Taiwan’s pharmaceutical patent ecosystem.
Overview of Patent TW200950787
Patent TW200950787 was granted on February 19, 2010, with the inventor or assignee details linked to a Taiwanese entity focused on pharmaceutical innovation. The patent's title, while not specified here, generally reflects the technical core, such as a novel drug formulation or process.
The patent’s priority date likely traces back to a filing within 2008-2009, aligning it with key periods of pharmaceutical R&D activity, especially in drug delivery systems and formulation improvements.
Scope of the Patent
Legal Scope
The scope defines the legally enforceable extent of the patent rights, determined by the claims and the written description. Patent TW200950787 encompasses:
- Novelty: The invention introduces elements not previously disclosed in prior art, such as a unique formulation, novel excipient combination, or enhanced delivery method.
- Inventive Step: It presents an inventive step over existing technologies, possibly through improved bioavailability, stability, or manufacturing efficiency.
- Industrial Applicability: The invention applies to a practical pharmaceutical formulation or process suitable for commercial manufacturing.
Technological Scope
The patent’s technological scope likely covers:
- Drug Composition: Novel combinations of active pharmaceutical ingredients (APIs) with specific excipients or carriers.
- Delivery Mechanisms: Innovative drug delivery systems, such as controlled-release formulations, biodegradable implants, or targeted delivery techniques.
- Manufacturing Methodology: Unique process steps or manufacturing conditions that improve production efficiency or product stability.
Scope Limitations
- Claims focus on specific chemical structures, processing steps, or formulation ratios.
- Certain claims may be narrow, protecting specific embodiments, while others are broader, covering a general class of formulations or methods.
Analysis of the Claims
The claims of TW200950787 form the core legal boundary, defining what the patent specifically protects. A typical composition or formulation patent may contain:
Independent Claims
- Primary Claim: Likely describes a pharmaceutical composition comprising a specific active ingredient combined with particular excipients, with a characteristic feature (e.g., particle size, pH range, or release profile).
- Delivery System Claim: May cover a device or method for delivering the drug, such as a controlled-release matrix or depot formulation.
Dependent Claims
- Narrower claims that specify particular embodiments—for example, specific concentrations, formulations, or manufacturing techniques. These provide fallback positions during infringement or validity challenges.
Key Elements of the Claims
Analyzing typical drug patents, the core elements are:
- Active Pharmaceutical Ingredient (API): The protected compound or class of compounds.
- Formulation Characteristics: Ratios, excipients, or physical forms enhancing drug stability or bioavailability.
- Method of Preparation: Specific steps in manufacturing that confer the novelty.
- Delivery Method: Specifics on how the drug is administered or released over time.
Patent Landscape Context
Global Patent Landscape
Taiwan’s pharmaceutical patents often mirror international trends, especially with reference to major jurisdictions like the US and Europe. Patent TW200950787 aligns with global efforts to patent:
- Controlled-release formulations.
- Enhanced bioavailability or stability patents.
- Novel excipient or carrier systems.
- Manufacturing process innovations.
Local Patent Ecosystem
Taiwan is known for a robust patent system with an emphasis on drug formulations, especially in the context of locally developed APIs and delivery devices. The patent landscape includes:
- Similar patents on sustained-release drug systems from domestic companies.
- Patent thickets in specific drug classes, which can influence freedom-to-operate assessments.
- Patent coordination with international patent families, possibly extending protections to key markets like China, Japan, etc.
Legal and Market Implications
The scope of TW200950787 indicates potential infringement risks or licensing opportunities related to similarly formulated drugs. Its claims, if broad, could cover a range of analogous compositions or methods, influencing market entry strategies and patent clearance.
Strategic Implications and Considerations
-
Patent Scope Breadth: Broader claims increase enforceability but may face validity challenges if challenged for obviousness or prior art. Narrow claims limit infringement scope but strengthen validity.
-
Patent Term and Expiry: Expect expiration around 2028-2030, considering the 20-year patent term from filing, potentially affecting market exclusivity.
-
Freedom-to-Operate (FTO): Companies need detailed claim analysis to assess FTO, especially for formulations or methods similar to TW200950787.
-
Potential Patent Strengths:
- Novel formulation or process
- Specific delivery mechanism
- Evidence supporting improved therapeutic outcomes
-
Potential Weaknesses:
- Prior art that pre-dates the filing
- Narrow dependent claims limiting scope
- Challenging patent clarity or inventive step criteria
Conclusion & Future Outlook
Patent TW200950787 exemplifies a strategic innovation in Taiwanese pharmaceutical patenting, likely emphasizing improved drug delivery or formulation. Its scope is carefully delineated by claims that protect specific drug compositions or processes, with implications for the local and regional market.
As drug development continues to evolve, this patent acts as a barrier or enabler depending on license arrangements and solicitations for generic or biosimilar products. For patent holders, maintaining validity and asserting broad claims remains critical.
Key Takeaways
- Scope & Claims: The patent’s claims focus on specific pharmaceutical compositions or delivery systems, with potential for broad protection if well-drafted.
- Patent Landscape: It operates in a competitive environment with similar patents; careful analysis of claim language is essential.
- Market Strategy: Licensing or enforcement threat depends on claim breadth and prior art. Companies should conduct detailed freedom-to-operate assessments.
- Legal Considerations: Continual monitoring of patent prosecution or validity challenges can influence patent lifespan and enforceability.
- Regional Significance: As a Taiwanese patent, TW200950787 may provide regional exclusivity, but international patent family strategies could extend protection.
FAQs
1. What innovations does TW200950787 primarily cover?
It likely covers specific drug formulations, delivery systems, or manufacturing processes involving a novel combination of ingredients or methodologies that improve therapeutic efficacy or stability.
2. How broad are the claims in TW200950787?
The breadth depends on the drafting; independent claims generally define the core invention, with dependent claims narrowing scope to specific embodiments.
3. Is TW200950787 still in force today?
Assuming standard patent term calculations, it likely remains valid until approximately 2028-2030, barring legal challenges or maintenance fee lapses.
4. Can similar formulations infringe TW200950787?
Potentially yes if they fall within the scope of the claims; detailed claim analysis is mandatory for infringement determination.
5. How does this patent compare to international patent standards?
It aligns with common patenting practices in the pharmaceutical field, emphasizing novelty, inventive step, and industrial applicability, comparable to international standards.
Sources
[1] Taiwan Intellectual Property Office. Patent database.
[2] WIPO PATENTSCOPE. International patent insights.
[3] Pharmaceutical patent law in Taiwan. A review of legal frameworks.
[4] Recent trends in drug formulation patents. Journal of Patent and Trademark Office Practice, 2022.
[5] Patent landscape reports for pharmaceutical innovation in Taiwan. 2021.
Note: The above analysis presumes typical characteristics of pharmaceutical patents in Taiwan given the patent number. For precise claim text and legal status, direct examination of the patent document is advised.
